Healthcare

Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Analysis 2019 Top companies are Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline plc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd

Global Monoamine Oxidase (MAO) Inhibitor Drugs Market

 Global Monoamine Oxidase (MAO) Inhibitor Drugs Market report includes the market overviews, market strategies of each vendor in the market  and also the understanding  about the market forces and how those can be exploited to create future opportunities. The Global Monoamine Oxidase (MAO) Inhibitor Drugs Market report studies present as well as future aspects of the Market primarily based upon factors on which the companies participate in the market growth, key trends and segmentation analysis.The industry changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the market.

Market Analysis:

Global monoamine oxidase (MAO) inhibitor drugs market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018.   Untapped emerging economies and competitive scenario of market and strategic collaborations are factors contributing positively towards the growth of this market.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-monoamine-oxidase-mao-inhibitor-drugs-market

Key Market Players:

Few of the major competitors currently working in the global monoamine oxidase (MAO) inhibitor drugs market are Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline plc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Bausch Health, Eli Lilly and Company, Orchid Chemicals & Pharamaceuticals Ltd., Validus Pharmaceuticals LLC, INDOCO REMEDIES LTD., Teikoku Pharma USA, Inc., H. Lundbeck A/S, Alliance Pharma PLC, AstraZeneca, Johnson & Johnson Services, Inc., Gedeon Richter Plc., Luye Pharma Group, Bristol-Myers Squibb Company, CeNeRx BioPharma, Inc. among others.

Key Developments in the Market:

  • In June 2017, Takeda Pharmaceutical Company Limited submitted a New Drug Application to the Ministry of Health, Labour and Welfare in Japan for rasagiline mesylate (TVP-1012), a selective irreversible monoamine oxidase type-B (MAO-B) inhibitor used for treatment for patients with Parkinson’s disease. Rasagiline mesylate is already developed by Teva Pharmaceutical Industries Ltd. and approved in the United States and Europe. If approved, it will enhance the product availability and helps patient through cost-effective treatment throughout Japan
  • In June 2017, Mylan N.V. launched Rasagiline which is generic version of Azilect for the treatment of Parkinson’s disease in the United States. The launch of rasagiline, provides the cost-effective treatment to the patients suffering from the Parkinson’s disease in the United States as well as broadens the company’s generic portfolio in the therapeutic area of CNS.

Global Monoamine Oxidase (MAO) Inhibitor Drugs Market By Types (MAO-A Inhibitor, MAO-B Inhibitor), Drugs (Isocarboxazid, Phenelzine, Tranylcypromine, Others), Disorder Type (Parkinson’s Disease, Depression, Anxiety, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Competitive Analysis:

Global monoamine oxidase (MAO) inhibitor drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of monoamine oxidase (MAO) inhibitor drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Definition: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market

Monoamine Oxidase (MAO) Inhibitors are the drugs that are used for treatment of depression. It works by prevention of breakdown of serotonin, dopamine, and norepinephrine in CNS and maintains their availability. These inhibitors possess huge risk of distributing other neurotransmitters in the brain and digestive system causing side effects. The major side effects of MAO inhibitors are high blood pressure, insomnia and weight gain.

The administration of MAO inhibitor drugs has been decreased in several years. During the year 1997 to 2006, the incidence rate of MAO inhibitors prescriptions has fallen from 3.1 per 100,000 to 1.4 per 100,000.

Table Of Content: Monoamine Oxidase (MAO) Inhibitor Drugs Market

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Monoamine Oxidase (MAO) Inhibitor Drugs Market
Part 04: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Sizing
Part 05: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Continue….

Market Drivers

  • Increasing patient pool of depression disorders worldwide acts as a driving factor for this market growth
  • Increasing government initiatives to spread awareness about the mental health among people will also boost the market growth in the forecast period
  • Rising geriatric population that are highly prone to have mental health issues will expand the market size
  • Surge of development of novel drugs and techniques with fewer side-effects will drive the market growth

Market Restraints

  • Side effects associated with MAO inhibitor are expected to restrain the market growth
  • Poor efficacy and safety profiles of the drug hampers the market growth
  • Increase in patent expiration of antidepressant drugs is weakening the pipeline; this factor will also restrict the growth of this market

Grab Your Report at an Impressive 30% Discount! Please click [email protected]https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-monoamine-oxidase-mao-inhibitor-drugs-market

Segmentation: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market

By Types

  • MAO-A Inhibitor
  • MAO-B Inhibitor

Drugs

  • Isocarboxazid
  • Phenelzine
  • Tranylcypromine
  • Others

By Disorder Type

  • Parkinson’s Disease
  • Depression
  • Anxiety
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Reasons to Purchase this Report

  • Current and future of global monoamine oxidase (MAO) inhibitor drugs market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

The report provides insights on the following points:

  1. Learn about the market strategies that are being adopted by your competitors and leading organizations
  2. Market Penetration: Comprehensive information on the product portfolios of the top players in the market
  3. To gain insightful analyses of the market and have a comprehensive understanding of the “Monoamine Oxidase (MAO) Inhibitor Drugs Market ” and its commercial landscape
  4. To understand the future outlook and prospects for Monoamine Oxidase (MAO) Inhibitor Drugs  Market  analysis and forecast 2019-2026.
  5. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

 

Table Of Content: Monoamine Oxidase (MAO) Inhibitor Drugs Market

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Monoamine Oxidase (MAO) Inhibitor Drugs Market
Part 04: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Sizing
Part 05: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Continue….

The report provides insights on the following points:

  1. Learn about the market strategies that are being adopted by your competitors and leading organizations
  2. Market Penetration: Comprehensive information on the product portfolios of the top players in the trocars market
  3. To gain insightful analyses of the market and have a comprehensive understanding of the “Monoamine Oxidase (MAO) Inhibitor Drugs Market ” and its commercial landscape
  4. To understand the future outlook and prospects for Monoamine Oxidase (MAO) Inhibitor Drugs  Market  analysis and forecast 2019-2026.
  5. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Report Rating
Close